The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2015

Filed:

May. 12, 2010
Applicants:

Molly S. Shoichet, Toronto, CA;

M. Douglas Baumann, St. Catharines, CA;

Catherine Elizabeth Kang, Chicago, IL (US);

Inventors:

Molly S. Shoichet, Toronto, CA;

M. Douglas Baumann, St. Catharines, CA;

Catherine Elizabeth Kang, Chicago, IL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/717 (2006.01); A61K 9/10 (2006.01); A61K 9/127 (2006.01); A61P 25/00 (2006.01); A61P 41/00 (2006.01); A61K 9/00 (2006.01); A61K 38/18 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0024 (2013.01); A61K 9/0095 (2013.01); A61K 38/1825 (2013.01); A61K 38/1858 (2013.01); A61K 38/1866 (2013.01); A61K 38/1891 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01);
Abstract

The present invention relates to a composite hydrogel comprising a blend of an aqueous solution of an anionic polysaccharide or a derivative thereof, such as hyaluronan (also commonly referred to as hyaluronic acid) or a derivative thereof and an aqueous solution of methylcellulose or another water soluble cellulose derivative thereof, having dispersed polymeric particles, such as polymeric hydrophobic particles therein selected from micro particles and nanoparticles, and wherein the stability of the hydrogel is enhanced relative to the stability of the hydrogel alone. The polymeric particles may contain at least one therapeutic agent, in which case each therapeutic agent exhibits a linear sustained release rate that can be tuned or altered by selecting the appropriate polymer formulation of the micro particles and/or nanoparticles. The composite may be injectable, and in the absence of a therapeutic agent may be used as a bulking agent for reconstructive and cosmetic surgery or may act as a platform for subsequent delivery of therapeutic agents.


Find Patent Forward Citations

Loading…